Drug intelligence / Profile preview

L-naphthyl-1-acetamido boronic acid alanine

Development stage
Unknown
Modality
Small Molecules
01

Overview

L-naphthyl‑1‑acetamido boronic acid alanine is a synthetic small molecule belonging to the class of naphthalene derivatives containing a boronic acid moiety. It has been studied primarily as an experimental transition-state analog inhibitor of serine proteases, such as alpha-chymotrypsin and subtilisin Carlsberg. The compound acts by forming a covalent tetrahedral adduct with the catalytic serine residue in the enzyme active site, mimicking the transition state of peptide bond hydrolysis and thereby inhibiting enzymatic activity. This mechanism makes it useful for probing stereoselectivity and binding interactions in protease research[5][7]. There are no approved therapeutic indications or marketed products containing this compound.

Other names
L-naphthyl-1-acetamido boronic acid alanineL-naphthyl1-acetamido boronic acid alanineL-naphthyl 1-acetamido boronic acid alanine((2S)-2-amino-2-carboxyethoxy)((1R)-1-acetamido-2-(naphthalen-1-yl)ethyl)dihydroxyboranuide[(2S)-2-amino-2-carboxyethoxy][(1R)-1-acetamido-2-(naphthalen-1-yl)ethyl]dihydroxyboranuide[(1R)-1-(acetylamino)-2-naphthalen-1‑ylethyl](dihydroxy)(L-serinato-kappaO~3~)borate(1‑)
02

Targets

CTRC (Chymotrypsin C)

Beyond the preview

Go deeper on L-naphthyl-1-acetamido boronic acid alanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-naphthyl-1-acetamido boronic acid alanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call